March 12, 2020
Bioness Announces First United Kingdom Implant for StimRouter Neuromodulation System at Leeds Teaching Hospitals NHS Trust
Following Regulatory Approval, Peripheral Nerve Stimulation Device for Chronic Pain Management Launches at Leading UK Hospital
Continue Reading
January 20, 2020
Bioness Announces StimRouter Milestones at 2020 North American Neuromodulation Society’s Annual Meeting
Company to sponsor Educational Session with leading clinical experts sharing insights on peripheral nerve stimulation
Continue Reading
January 16, 2020
Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence
StimRouter also available in Europe for managing chronic pain and overactive bladder
Continue Reading
December 19, 2019
Bioness Introduces Improved Training Platform for Surgeons Expanding Their Practice to Include the StimRouter Peripheral Nerve Stimulator
Attendees of the 2020 NANS Conference Will be First Clinical Professionals to Review
Continue Reading
November 13, 2019
Published Clinical Success for Bioness StimRouter Peripheral Nerve Stimulator
Bioness, Inc., the leading provider of the advanced, clinically supported StimRouter® Peripheral Nerve Stimulator, announced a publication entitled “Prospective Case Series on the Use of Peripheral Nerve Stimulation for Focal Mononeuropathy Treatment” in the journal Pain Management on November 6, 2019.
Continue Reading
September 04, 2019
Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence Society Annual Meeting
StimRouter helping improve lives of patients in Europe and Australia beyond the management of chronic pain
Continue Reading
March 13, 2019
Bioness Announces First Australian Implant of StimRouter® Neuromodulation System at Nambour Selangor Private Hospital
Device now available in Australia for the management of chronic pain
Continue Reading
February 18, 2019
Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)
StimRouter now available in Europe beyond the management of chronic pain
Continue Reading
January 17, 2019
Bioness to Sponsor Educational Session on Peripheral Nerve Stimulation at 2019 North American Neuromodulation Society’s Annual Meeting
Clinical experts will share insights on present and future applications of neuromodulation technology
Continue Reading
January 14, 2019
Bioness Introduces First Peripheral Nerve Stimulation Registry with its StimRouter™ Neuromodulation System
The company continues to lead the market through the collection of PNS outcomes and ongoing education
Continue Reading